Description

Peg Zuvigrast (Pegfilgrastim Injection 6 mg) belongs to the Supportive Cancer Care category and is used to help reduce the risk of chemotherapy-induced neutropenia, a condition in which white blood cell counts become dangerously low after cancer treatment. Pegfilgrastim is a long-acting Granulocyte Colony-Stimulating Factor (G-CSF) that stimulates the bone marrow to produce neutrophils, helping the body fight infections during chemotherapy. This category includes Pegfilgrastim 6 mg injections intended for use in oncology hospitals, cancer treatment centers, specialty clinics, and licensed pharmacies. The medicine is typically administered under the supervision of qualified healthcare professionals as part of supportive care for patients receiving myelosuppressive chemotherapy. Our selection of Pegfilgrastim injections is manufactured in WHO-GMP compliant facilities and is available for international pharmaceutical export, wholesale distribution, and institutional procurement. Products are supplied with secure packaging and reliable worldwide shipping in accordance with applicable export regulations. Category Highlights Long-acting Pegfilgrastim (G-CSF) injection for supportive cancer care Helps reduce the risk of chemotherapy-induced neutropenia and febrile neutropenia 6 mg/0.6 mL prefilled syringe formulation Manufactured in WHO-GMP compliant pharmaceutical facilities Suitable for hospitals, oncology clinics, specialty pharmacies, and distributors Available for wholesale, institutional supply, and international export Secure packaging and reliable global shipping Prescription-only medicine to be used under the supervision of qualified healthcare professionals.